Tag: biotech

For a long time, the research and development of each new drug has faced the challenges of high cost and long cycle. In response to these challenges, major pharmaceutical companies have shifted from targeting common diseases to developing drugs for specific diseases. At the same time, these companies are constantly looking for new technologies for new drug development, such as high-throughput screening technology, DNA encoded chemical library, computer-aided drug discovery, and artificial intelligence. The use of computer simulation for drug development may reduce costs and increase the efficiency and success rate…

Read More

Coupling drugs combine the precise targeting and potent killing properties, has become a widely recognized form of medication in recent years. Radioactive drug conjugates (RDCs), as a particular form of coupling drugs, are formed by combining radioactive isotopes with disease-targeting molecules. According to the application of RDCs, they can be divided into two main categories: diagnostic RDCs and therapeutic RDCs. γ-emitting isotopes are selected for diagnosis because the radiation they produce can be detected by specific instruments such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT), assisting…

Read More

Antibody-drug conjugates (ADCs) have emerged as a promising class of treatments in the evolving field of cancer treatment. ADCs combine the potency of cytotoxic drugs with the selectivity of monoclonal antibodies, providing a novel approach to targeted therapy. ADCs show great promise in the fight against cancer and have the potential to be game-changers for targeted therapies across a range of non-oncology indications. What is Antibody-Drug Conjugate? ADCs represent an important class of cancer therapies that have revolutionized the treatment paradigm for solid tumors. To date, many ongoing studies of ADCs…

Read More

  CD BioSciences, a prominent biotech company, has recently unveiled its latest and innovative service on cytoskeleton-based tumor marker development. This groundbreaking service can be utilized for preclinical tests to determine the tumor type and predict disease progression.   The cytoskeleton refers to the network of protein filaments within cells that plays a crucial role in maintaining their basic structure and performing actions. The structure, function, and dynamic behavior of the cytoskeleton may vary greatly depending on the organism and cell type. Even within one cell, the cytoskeleton can be…

Read More

  Recently, CD BioSciences has announced the release of marine drug development services aiming to move forward the frontier of this area. Utilizing cutting-edge marine biological analysis techniques and unique platforms, CD BioSciences provides customers with tailored research services to produce efficient marine pharmaceutical products for cancer therapies.   “Our company is a biotechnology service provider of marine resource development and marine biological analysis. We hope to empower researchers to make full use of marine organisms in their drug research,” said the marketing manager of CD BioSciences. “We feel proud…

Read More